英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
interfold查看　interfold　在百度字典中的解释百度英翻中〔查看〕
interfold查看　interfold　在Google字典中的解释Google英翻中〔查看〕
interfold查看　interfold　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    GLP-1 receptor agonists and hospitalization due to infections in patients with type 2 diabetes: A nationwide cohort study, Diabetes Research and Clinical Practice, 226, (112324), (2025) https
  • High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and . . .
    A phase 3 study with evaluation of a 7 2-mg dose of semaglutide for weight management in adults with type 2 diabetes and higher BMI (>30 kg m 2) is underway (clinical trial reg no NCT05649137, ClinicalTrials gov) and may shed further light on the efficacy and tolerability of high-dose semaglutide with dosing flexibility that closer models
  • Real world effectiveness of subcutaneous semaglutide in type 2 diabetes . . .
    Therefore, the aim of the present study was to assess effectiveness and safety of OW semaglutide when used in T2D patients managed by a network of diabetes clinics Materials and methods This was a multicenter, observational, retrospective study, aiming to investigate the use and the impact of OW semaglutide after 6 and 12 months of treatment
  • Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg . . .
    GLP-1 receptor agonists are recommended for the treatment of type 2 diabetes owing to their ability to improve glycaemic control and reduce bodyweight, with some also having shown cardiovascular risk reduction 3 Semaglutide, a long-acting human GLP-1 analogue, is approved for the treatment of type 2 diabetes as an adjunct to diet and exercise and is available both as once-weekly subcutaneous
  • Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in . . .
    Background: Semaglutide is an effective treatment for type 2 diabetes; however, 20-30% of patients given semaglutide 1·0 mg do not reach glycaemic treatment goals We aimed to investigate the efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in adults with inadequately controlled type 2 diabetes on a stable dose of metformin with or without a sulfonylurea
  • Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
    Semaglutide was initiated at a dose of 0 25 mg once weekly, and the dose was doubled every 4 weeks until 1 mg was reached (ADA) and the European Association for the Study of Diabetes (EASD)
  • 230-OR: Comparative Effectiveness of Semaglutide in Type 2 Diabetes . . .
    The objective of this study was to generate real-world evidence to support clinical decision-making by evaluating the long-term effects of once-weekly SC s , BRIAN J HARTY, HELENE NORDAHL, MARK J CZIRAKY, VINCENT WILLEY, SIMON SKIBSTED; 230-OR: Comparative Effectiveness of Semaglutide in Type 2 Diabetes—Year 2 Results of a Randomized
  • Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic . . .
    This study mentioned that semaglutide-1mg had the best effect on weight reduction [43] However, its safety profile was not satisfactory [43] Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis Diabetes Obes Metabol, 20 (9) (2018), pp 2255-2263
  • New Real-World Study by Columbia Data Analytics Confirms Semaglutide . . .
    Citation: Baser O, Lu Y External control arm with real world data to assess the effect of semaglutide on chronic kidney disease risk among patients with type 2 diabetes Expert Opinion on
  • Semaglutide for the Treatment of Type 2 Diabetes Mellitus
    Abstract Objective: To detail studies investigating the efficacy safety of semaglutide as a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the treatment of type 2 diabetes mellitus Data Sources: A literature search in MEDLINE and ClinicalTrials gov (January 2013 to May 2018) using the terms semaglutide, SUSTAIN, oral, and PIONEER resulted in 10 published articles and 14 ongoing





中文字典-英文字典  2005-2009